Recent reporting, background, and summaries from the health desk.
The World Health Organization has declared an Ebola outbreak in the Democratic Republic of Congo and Uganda a "public health emergency of international concern," specifically due to the rare Bundibugyo virus. This deadly strain, for which no approved vaccines or treatments currently exist, has already caused over 80 deaths and 246 suspected cases, with ongoing conflict further complicating containment efforts.
The U.S. Supreme Court has temporarily blocked restrictions on mifepristone, a widely used abortion pill, ensuring continued access for patients nationwide. This crucial decision means doctors can still mail the medication directly to individuals without requiring an in-person visit, preserving the most common method of ending a pregnancy in the U.S.
The CDC has reported a grim milestone, revealing suicide is now a top 10 cause of death in the U.S., with nearly 49,000 Americans dying by suicide in 2024 alone. This alarming surge, linked to rising mental health conditions, has prompted calls for mandatory suicide risk screening during all healthcare visits to identify and help at-risk individuals.
A groundbreaking new drug, daraxonrasib, is showing incredible promise in substantially extending the lives of pancreatic cancer patients by targeting specific cellular proteins that fuel cancer growth. This innovative treatment, which could also impact lung and colon cancers, is currently on fast-track FDA review and might be approved later this year, offering a beacon of hope.
French authorities have confined over 1,700 passengers and crew aboard the British cruise ship Ambition in Bordeaux following a gastrointestinal illness outbreak and a passenger's death. This drastic measure was enacted after approximately 50 individuals, including guests and one crew member, fell ill with suspected norovirus, prompting a full lockdown.
A new special report reveals that climate change is profoundly impacting mental health, not only worsening existing conditions but also triggering entirely new disorders. Experts are now highlighting climate-related anxiety, depression, and grief as urgent issues demanding immediate recognition and action.
An alarming hantavirus outbreak aboard the MV Hondius cruise ship has tragically led to 8 infections and 3 deaths, with five cases identified as the Andes virus, known for its limited human-to-human transmission. As the ship sails towards the Canary Islands, health officials are monitoring disembarked passengers while experts question the CDC's response to this unfolding crisis.
A deadly hantavirus outbreak aboard a cruise ship has tragically claimed three lives, sparking international alarm as the WHO investigates a rare human-to-human transmission of the Andes strain. This serious health crisis has prompted global coordination, with nations tracking their citizens and health officials actively monitoring passengers and facilitating evacuations from the affected vessel.
A suspected hantavirus outbreak on the MV Hondius cruise ship has tragically claimed three lives, including an elderly couple, prompting an urgent investigation by the World Health Organization and South Africa's health department. With at least one case officially confirmed and others critically ill or being evacuated, authorities are scrambling to contain the spread as the vessel traveled between Argentina and Cape Verde.
Startling new research indicates that even "low-risk" alcohol consumption is linked to reduced brain blood flow and a thinner cortex, challenging previous notions of safe drinking levels. This impact is particularly pronounced in older adults, suggesting that cumulative effects over time may pose a significant, age-related risk to brain health.
New research reveals that individuals with advanced cardiovascular-kidney-metabolic (CKM) syndrome face a significantly higher risk of developing cancer, with a study of nearly 1.4 million adults showing a 25-30% increased likelihood in later stages. This critical finding, published by the American Heart Association, underscores the profound interconnectedness of heart, kidney, and metabolic health with broader long-term health outcomes.
A groundbreaking new pill, daraxonrasib, has demonstrated remarkable success in clinical trials for metastatic pancreatic cancer, effectively doubling patients' median survival time from 6.7 to 13.2 months. This significant breakthrough offers renewed hope by targeting specific cancer cell pathways, providing a much-needed therapeutic option for a previously intractable disease.